Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.84, $0.53 better than the analyst estimate of $0.31. Revenue for the quarter came in at $637.2 million versus the consensus estimate of $465.97 million.

GUIDANCE:

Exelixis sees FY2024 revenue of $1.975-2.075 million, versus the consensus of $1.879 million.

For earnings history and earnings-related data on Exelixis (EXEL) click here.